|
|
|
Volumn 21, Issue 2, 1994, Pages 220-235
|
|
The chemotherapy of high-grade astrocytomas
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CARMUSTINE;
CISPLATIN;
CONTRAST MEDIUM;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DNA TOPOISOMERASE;
DOXORUBICIN;
ELMUSTINE;
ETOPOSIDE;
FLUOROURACIL;
GLUCOCORTICOID;
HYDROXYUREA;
LOMUSTINE;
MANNITOL;
METHOTREXATE;
MITHRAMYCIN;
NIMUSTINE;
PACLITAXEL;
PLASMA PROTEIN;
PROCARBAZINE;
SEMUSTINE;
TEMOZOLOMIDE;
TENIPOSIDE;
THIOTEPA;
TOPOTECAN;
VINCRISTINE;
ASTROCYTOMA;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BLOOD BRAIN BARRIER;
BONE MARROW SUPPRESSION;
BRAIN EDEMA;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG SOLUBILITY;
EYE TOXICITY;
GLIOBLASTOMA;
HUMAN;
INTERSTITIAL PNEUMONIA;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
NEUROTOXICITY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
ASTROCYTOMA;
BLOOD-BRAIN BARRIER;
BONE MARROW TRANSPLANTATION;
BRAIN NEOPLASMS;
CLINICAL TRIALS;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
|
|
EID: 0028353403
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (78)
|
|
References (0)
|
